Your browser doesn't support javascript.
loading
Pharmacological Basis for Abrogating Myocardial Reperfusion Injury Through a Multi-Target Combined Antioxidant Therapy.
San-Martín-Martínez, Daniel; Serrano-Lemus, Dayanara; Cornejo, Vicente; Gajardo, Abraham I J; Rodrigo, Ramón.
Afiliação
  • San-Martín-Martínez D; Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Avda. Independencia 1027, CP 8380453, Santiago, Región Metropolitana, Chile.
  • Serrano-Lemus D; Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Avda. Independencia 1027, CP 8380453, Santiago, Región Metropolitana, Chile.
  • Cornejo V; Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Avda. Independencia 1027, CP 8380453, Santiago, Región Metropolitana, Chile.
  • Gajardo AIJ; Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Avda. Independencia 1027, CP 8380453, Santiago, Región Metropolitana, Chile.
  • Rodrigo R; Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Avda. Independencia 1027, CP 8380453, Santiago, Región Metropolitana, Chile. rrodrigo@med.uchile.cl.
Clin Pharmacokinet ; 61(9): 1203-1218, 2022 09.
Article em En | MEDLINE | ID: mdl-35871676

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article